Contains viable, selected strains of human adenovirus type 4 and human adenovirus type 7 prepared in human-diploid fibroblast cell cultures (strain wi-38); virus strains have not been attenuated; cells are grown and the virus growth maintained in dulbecco's modified eagle's medium, fetal bovine serum, and sodium bicarbonate; approved for use in military populations 17-50 years of age; indicated for active immunization for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7; carton consists of one bottle of 100 tablets adenovirus type 4 (ndc 51285-174-02) and one bottle of 100 tablets adenovirus type 7 (ndc 51285-175-02); store refrigerated between 2-8 degrees c (35-46 degrees f); do not freeze; keep bottle tightly closed and protect from moisture; do not remove desiccant canister from bottle; prescription only; for oral administration; dosage: one tablet of adenovirus type 4 component and one tablet of adenovirus type 7 component
NSN 5920-01-538-5737
NSN 6130-01-432-2855
NSN 5905-01-575-9084
NSN 4140-01-113-8886
NSN 5910-01-513-6221
NSN 5999-01-012-1934
NSN 5990-01-270-3209
NSN 6645-01-343-1676
NSN 6220-00-902-7328
NSN 5835-01-546-2008
NSN 6685-01-616-4357
NSN 5996-01-513-1388